Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen | Immunology | Best Researcher Award

Dr. Abraham Teunissen, Icahn school of medicine, United States.

Dr. Abraham J. P. Teunissen ๐ŸŽ“ is an Assistant Professor at the Biomedical Engineering and Imaging Institute, Icahn School of Medicine, New York ๐Ÿ—ฝ. He leads groundbreaking research in nanomedicine, radiochemistry, and immunotherapy ๐Ÿงฌ. With a Ph.D. in Molecular Engineering, he has authored high-impact studies and holds key patents. Dr. Teunissen mentors future scientists ๐Ÿ‘จโ€๐Ÿ”ฌ๐Ÿ‘ฉโ€๐Ÿ”ฌ and champions diversity and inclusion. His work on trained immunity and advanced imaging technologies is shaping the future of personalized medicine ๐ŸŒŸ.

๐ŸŒŸ Professional Profile

๐ŸŽ“Early Academic Pursuitsย 

Abraham J. P. Teunissen, Ph.D., embarked on his academic journey at Fontys University of Applied Science, earning a B.ASc in Organic Chemistry in 2011, where he developed supramolecular polymers for improved hemodialysis. He continued at Eindhoven University of Technology, securing an M.Sc. in Molecular Engineering (2013) and completing a Ph.D. (2017) focused on competing interactions in chemical reaction networks. His early research on biomimetic systems and chemical networks laid the foundation for a distinguished career in biomedical sciences.

๐ŸขProfessional Endeavorsย 

Dr. Teunissenโ€™s professional journey showcases a trajectory of growth and leadership. He held appointments at the prestigious Icahn School of Medicine at Mount Sinai, progressing from Postdoctoral Scientist (2017) to Instructor (2019), and ultimately to Assistant Professor (2022). He also serves as the Director of Radiochemistry at the Biomedical Engineering and Imaging Institute. Beyond academia, he consulted for Trained Therapeutix Discovery, driving translational innovation from 2019 to 2021.

๐Ÿ”ฌContributions and Research Focus On Immunologyย 

Dr. Teunissen has made notable contributions to nanomedicine, immunology, and molecular imaging. His research lab develops novel nanotherapies and imaging probes to modulate and monitor the immune system in various diseases โ€” including cancer, cardiovascular disease, diabetes, and organ transplantation. His teamโ€™s work spans small and large animal models, advancing therapeutic strategies with clinical relevance. His radiochemistry facility supports diverse collaborations, innovating nanoparticle tracking and immune monitoring using immuno-PET technology.

๐ŸŒŽImpact and Influenceย 

The outcomes of Dr. Teunissen’s research have wide-reaching impacts. His lab’s pioneering work on trained immunity modulation has driven forward collaborations, clinical translation efforts, and even the founding of a biotech company, Trained Therapeutix Discovery. His immuno-PET technologies enhance understanding of disease mechanisms and inform therapeutic interventions, demonstrating translational significance from bench to bedside.

๐Ÿ“šAcademic Cites and High-Impact Publicationsย 

Dr. Teunissen’s work has appeared in leading journals such as Cell, Nature Biomedical Engineering, Nature Nanotechnology, and Science Translational Medicine. His high citation count reflects the significance of his research, especially in trained immunity, nanomedicine, and molecular imaging fields. These citations highlight his contributions to both fundamental science and applied biomedical research.

๐Ÿ†Awards and Honorsย 

While specific individual awards were not detailed, Dr. Teunissen’s achievements include serving as an ad-hoc NIH and American Cancer Society grant reviewer, organizing major scientific symposia, and designing graduate-level coursework. His leadership roles โ€” like incident commander and scientific advisory organizer โ€” reflect high institutional trust and professional recognition.

๐Ÿ”ฎLegacy and Future Contributionsย 

Dr. Teunissenโ€™s legacy is rooted in scientific excellence, mentorship, and innovation. With an active lab mentoring a diverse group of postdocs, graduate, and premedical students, he is shaping the next generation of biomedical engineers and nanomedicine scientists. His future contributions are expected to further bridge fundamental science and clinical application, aiming to improve therapeutic outcomes for major diseases through immune modulation and advanced molecular imaging. His strong commitment to diversity, inclusion, and education ensures a lasting positive impact on both science and society.

๐Ÿ“šPublications Top Notes

  • Development of Methods for the Determination of pKa Values
    ๐Ÿ“ฐ Analytical Chemistry Insights | ๐Ÿ“‘ 483 citations | ๐Ÿ“… 2013

  • Investigating Supramolecular Systems Using Fรถrster Resonance Energy Transfer
    ๐Ÿ“ฐ Chemical Society Reviews | ๐Ÿ“‘ 159 citations | ๐Ÿ“… 2018

  • Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
    ๐Ÿ“ฐ Cell | ๐Ÿ“‘ 145 citations | ๐Ÿ“… 2020

  • Efficacy and Safety Assessment of a TRAF6-Targeted Nanoimmunotherapy in Atherosclerotic Mice and Non-Human Primates
    ๐Ÿ“ฐ Nature Biomedical Engineering | ๐Ÿ“‘ 128 citations | ๐Ÿ“… 2018

  • End Groups of Functionalized Siloxane Oligomers Direct Block-Copolymeric or Liquid-Crystalline Self-Assembly Behavior
    ๐Ÿ“ฐ Journal of the American Chemical Society | ๐Ÿ“‘ 110 citations | ๐Ÿ“… 2016

  • Tumor Targeting by ฮฑvฮฒ3-Integrin-Specific Lipid Nanoparticles Occurs via Phagocyte Hitchhiking
    ๐Ÿ“ฐ ACS Nano | ๐Ÿ“‘ 93 citations | ๐Ÿ“… 2020

  • Directing the Selfโ€Assembly Behaviour of Porphyrinโ€Based Supramolecular Systems
    ๐Ÿ“ฐ Chemistry โ€“ A European Journal | ๐Ÿ“‘ 82 citations | ๐Ÿ“… 2017

  • Imaging-Assisted Nanoimmunotherapy for Atherosclerosis in Multiple Species
    ๐Ÿ“ฐ Science Translational Medicine | ๐Ÿ“‘ 68 citations | ๐Ÿ“… 2019

  • Prosaposin Mediates Inflammation in Atherosclerosis
    ๐Ÿ“ฐ Science Translational Medicine | ๐Ÿ“‘ 65 citations | ๐Ÿ“… 2021

  • Nuclear Imaging Approaches Facilitating Nanomedicine Translation
    ๐Ÿ“ฐ Advanced Drug Delivery Reviews | ๐Ÿ“‘ 63 citations | ๐Ÿ“… 2020

  • Probing Myeloid Cell Dynamics in Ischaemic Heart Disease by Nanotracer Hot-Spot Imaging
    ๐Ÿ“ฐ Nature Nanotechnology | ๐Ÿ“‘ 61 citations | ๐Ÿ“… 2020

  • Mechanically Induced Gelation of a Kinetically Trapped Supramolecular Polymer
    ๐Ÿ“ฐ Macromolecules | ๐Ÿ“‘ 52 citations | ๐Ÿ“… 2014

  • Imaging Cardiovascular and Lung Macrophages with the Positron Emission Tomography Sensor 64Cu-Macrin in Mice, Rabbits, and Pigs
    ๐Ÿ“ฐ Circulation: Cardiovascular Imaging | ๐Ÿ“‘ 44 citations | ๐Ÿ“… 2020

  • Resolving Sepsis-Induced Immunoparalysis via Trained Immunity by Targeting Interleukin-4 to Myeloid Cells
    ๐Ÿ“ฐ Nature Biomedical Engineering | ๐Ÿ“‘ 37 citations | ๐Ÿ“… 2023

  • A Modular Approach Toward Producing Nanotherapeutics Targeting the Innate Immune System
    ๐Ÿ“ฐ Science Advances | ๐Ÿ“‘ 35 citations | ๐Ÿ“… 2021

  • An Iterative Sparse Deconvolution Method for Simultaneous Multicolor 19Fโ€MRI of Multiple Contrast Agents
    ๐Ÿ“ฐ Magnetic Resonance in Medicine | ๐Ÿ“‘ 30 citations | ๐Ÿ“… 2020

ย 

dongmei shi | Immunology | Global Impact in Research Award

Dr. Dongmei shi | Immunology | Global Impact in Research Award

Dr. Dongmei shi, Jining NO.1 peoples’ hospital, China.

Dr. Dongmei Shi ๐Ÿงช is a Professor of Dermatology at Jining No.1 Peopleโ€™s Hospital, specializing in medical mycology ๐Ÿฆ  and infection immunology ๐Ÿ›ก๏ธ. She has discovered new fungal species, revealed immune evasion pathways, and developed innovative diagnostic tools ๐Ÿ”ฌ. A leader in clinical and translational research, Dr. Shi has led several nationally funded projects ๐Ÿ‡จ๐Ÿ‡ณ and serves on prestigious medical committees ๐Ÿ‘ฉโ€โš•๏ธ. Her work significantly advances skin infection treatment and global dermatological science ๐ŸŒ.

๐ŸŒŸ Professional Profile

Scopus profile

๐ŸŽ“ Early Academic Pursuits

Dr. Dongmei Shi earned her doctoral degree in Dermatology and Venereology from the esteemed Fourth Military Medical University. Her academic foundation was built on rigorous training and a commitment to deepening her understanding of skin disorders and infections. From the outset, she demonstrated a keen interest in medical mycology and infection immunology, which laid the groundwork for her future innovations and research contributions.

๐Ÿ’ผ Professional Endeavors

Currently serving as a Professor in the Department of Dermatology and the Medical Mycology Laboratory at Jining NO.1 Peopleโ€™s Hospital, Dr. Shi has built an impressive career. With years of clinical experience, she excels in diagnosing and treating a wide range of skin diseases. Her work merges clinical acumen with scientific inquiry, making her a pivotal figure in integrating patient care with research-driven solutions.

๐Ÿ”ฌ Contributions and Research Focus On Immunologyย 

Dr. Shiโ€™s research spans the taxonomy of medical fungi, the pathogenicity of fungal infections, and the immune responses triggered by skin pathogens. She has discovered novel fungal species and immune evasion pathways that pave the way for targeted antifungal drug development. Her innovation extends to clinical technologies, including a rapid fungal detection kit and novel treatment strategies using phototherapy and biologics, improving diagnostic precision and therapeutic outcomes.

๐ŸŒ Impact and Influence

Her findings have redefined aspects of fungal taxonomy and infection immunology, directly impacting clinical practices and theoretical knowledge in dermatology. Through her projects funded by the National Natural Science Foundation of China and provincial bodies, she has created platforms for translational research, driving both academic progress and patient care. Her rapid diagnostic tools and immunotherapy strategies are increasingly recognized in the medical community.

๐Ÿ† Awards and Honors

Dr. Shiโ€™s leadership and scholarly impact have earned her positions in multiple prestigious organizations. She is a Council Member of the Asia-Pacific Medical Mycology Society, Editorial Board Member of the Chinese Journal of Mycology, and Executive Committee Member in various national dermatological and medical mycology societies. These roles recognize her excellence and her influential voice in shaping dermatological science.

๐Ÿ“ŠAcademic Citations

Dr. Shi has published numerous high-quality papers in top-tier dermatological and mycological journals, significantly contributing to the body of literature in her field. Her work on Candidalysin pathways, dendritic cell modulation, and immune response mechanics is frequently cited by peers, reflecting the global relevance and scientific rigor of her research.

๐Ÿš€ Legacy and Future Contributions

Dr. Dongmei Shi stands as a beacon of innovation in dermatology, bridging research, clinical practice, and technology. Her future work aims to further unravel the complex interplay between fungal pathogens and immune responses, explore personalized immunotherapy, and advance standardization in dermatological diagnostics. As she continues to lead groundbreaking studies and mentor emerging scholars, her legacy is set to inspire generations of medical professionals. ๐ŸŒฑ

๐Ÿ“šPublications Top Notes

1๏ธโƒฃ Photodynamic therapy combined with palliative resection and secondary healing for periocular basal cell carcinoma with inadequate surgical margins

๐Ÿ‘ฉโ€โš•๏ธ Authors: X. Wang, T. Zhang, T. Li, Y. Song, D. Shi, Dongmei
๐Ÿ—“๏ธ Journal: Photodiagnosis and Photodynamic Therapy
๐Ÿ“… Year: 2025
๐Ÿ”ฌ Type: Article

2๏ธโƒฃ Successful management of recurrent cutaneous granulomas caused by Candida albicans using aminolevulinic acid photodynamic therapy post-surgery: A case report

๐Ÿ‘ฉโ€โš•๏ธ Authors: L. Wang, Y. Feng, S. Wang, Z. Yang, D. Shi, Dongmei
๐Ÿ—“๏ธ Journal: Photodiagnosis and Photodynamic Therapy
๐Ÿ“… Year: 2025
๐Ÿ“ Type: Case Report

3๏ธโƒฃ Immunoglobulin E, the potential accelerator of comorbid psoriasis and atherosclerosis

๐Ÿ‘ฉโ€โš•๏ธ Authors: Y. Wang, D. Li, Z. Yan, D. Shi, Dongmei
๐Ÿ”ข Citations: 1
๐Ÿงช Type: Review

4๏ธโƒฃ Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review)

๐Ÿ‘ฉโ€โš•๏ธ Authors: J. Zhang, Y. Feng, D. Li, D. Shi, Dongmei
๐Ÿงฌ Type: Review

5๏ธโƒฃ Decoding the enigmatic role of T-cadherin in tumor angiogenesis

๐Ÿ‘ฉโ€โš•๏ธ Authors: H. Xiong, D. Shi, Dongmei
๐Ÿง  Type: Review

6๏ธโƒฃ Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China

๐Ÿ‘ฉโ€โš•๏ธ Authors: P. Cui, D. Li, L. Shi, R. Li, D. Shi, Dongmei
๐Ÿ—“๏ธ Journal: Scientific Reports
๐Ÿ“… Year: 2024
๐Ÿ”ข Citations: 2
๐Ÿ“Š Type: Article

7๏ธโƒฃ Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates

๐Ÿ‘ฉโ€โš•๏ธ Authors: D. Shi, Dongmei, Z. Yang, W. Liao, S. de Hoog, S. Deng
๐Ÿ—“๏ธ Journal: IMA Fungus
๐Ÿ“… Year: 2024
๐Ÿ”ข Citations: 2
๐Ÿงซ Type: Article

8๏ธโƒฃ Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition)

๐Ÿ‘ฉโ€โš•๏ธ Authors: G. Liang, X. Li, R. Li, X. Kong, W. Liu
๐Ÿ—“๏ธ Journal: Mycoses
๐Ÿ“… Year: 2024
๐Ÿ“œ Type: Consensus Statement